13D/13G Filings - Vizirgianakis Stavros G.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-05-09
07:45 am
Unchanged
2024-05-07 13D Apyx Medical Corporation
APYX
Vizirgianakis Stavros G. 1,746,191
5.040%
0
(Unchanged)
Filing
History
2024-04-01
4:15 pm
Purchase
2024-03-25 13D Apyx Medical Corporation
APYX
Vizirgianakis Stavros G. 1,746,191
5.040%
1,746,191increase
(New Position)
Filing
History
2022-09-06
2:19 pm
Purchase
2022-08-25 13D Xtant Medical Holdings, Inc.
XTNT
Vizirgianakis Stavros G. 7,224,924
6.620%
7,224,924increase
(New Position)
Filing
History